Ex Parte Fuisz et alDownload PDFPatent Trial and Appeal BoardFeb 23, 201713423527 (P.T.A.B. Feb. 23, 2017) Copy Citation United States Patent and Trademark Office UNITED STATES DEPARTMENT OF COMMERCE United States Patent and Trademark Office Address: COMMISSIONER FOR PATENTS P.O.Box 1450 Alexandria, Virginia 22313-1450 www.uspto.gov APPLICATION NO. FILING DATE FIRST NAMED INVENTOR ATTORNEY DOCKET NO. CONFIRMATION NO. 20386-135275 9248 EXAMINER RAMACHANDRAN, VASUDA ART UNIT PAPER NUMBER 3735 MAIL DATE DELIVERY MODE 13/423,527 03/19/2012 Richard C. Fuisz 42798 7590 02/23/2017 FITCH, EVEN, TAB IN & FLANNERY, LLP 120 South LaSalle Street, Suite 1600 Chicago, IL 60603-3406 02/23/2017 PAPER Please find below and/or attached an Office communication concerning this application or proceeding. The time period for reply, if any, is set in the attached communication. PTOL-90A (Rev. 04/07) UNITED STATES PATENT AND TRADEMARK OFFICE BEFORE THE PATENT TRIAL AND APPEAL BOARD Ex parte RICHARD C. FUISZ and JOSEPH M. FUISZ Appeal 2017-000581 Application 13/423,527 Technology Center 3700 Before PATRICK R. SCANLON, GEORGE R. HOSKINS, and GORDON D. KINDER, Administrative Patent Judges. HOSKINS, Administrative Patent Judge. DECISION ON APPEAL STATEMENT OF THE CASE Richard C. Fuisz and Joseph M. Fuisz (“Appellants”)1 appeal under 35 U.S.C. § 134 from the Examiner’s decision rejecting claims 1 and 3—16 in this application. Claim 2 is canceled. Appeal Br. (Claims App.). The Board has jurisdiction over the appeal under 35 U.S.C. § 6(b). An oral hearing was held on February 14, 2017. We REVERSE. 1 The Appeal Brief identifies Appellants as the real parties in interest. Appeal Br. 1. 1 Appeal 2017-000581 Application 13/423,527 CLAIMED SUBJECT MATTER Claims 1,15, and 16 are independent. Claim 1 illustrates the subject matter on appeal, and it recites: 1. A method of avoiding a contaminant which would skew an analyte result in a breath analysis method and of calibrating subject of the breath analysis comprising, immediately before a breath analysis method or collection of breath for a breath analysis method, administering to the subject a predetermined purified and standardized gas composition not comprising ambient air, the predetermined gas composition being free of a contaminant which would skew an analyte result in a breath analysis method. Appeal Br. (Claims App.) (line breaks added). REJECTIONS ON APPEAL Claims 1, 3, 12, 13, and 15 stand rejected under 35 U.S.C. § 102(b) as anticipated by Wang (US 2010/0137733 Al, pub. June 3, 2010). Claims 4—6, 9, 11, and 16 stand rejected under 35 U.S.C. § 103(a) as unpatentable over Wang. Claims 7, 8, and 10 stand rejected under 35 U.S.C. § 103(a) as unpatentable over Wang and Restrepo (RD Restrepo & BK Walsh, Humidification during invasive and noninvasive mechanical ventilation: 2012, Respiratory Care, vol. 57(5), pp. 782—788 (May 2012)). Claim 14 stands rejected under 35 U.S.C. § 103(a) as unpatentable over Wang and Clemensen (US 2011/0098589 Al, pub. Apr. 28, 2011). 2 Appeal 2017-000581 Application 13/423,527 ANALYSIS A. Anticipation by Wang In rejecting claim 1 as anticipated by Wang, the Examiner finds Wang’s paragraph 48 discloses the claimed administration of “a predetermined purified and standardized gas composition not comprising ambient air.” Final Act. 3. The cited Wang disclosure provides: [T]he methods optionally include a “lung washout,” protocol wherein several deep breaths are taken with pure air by the individual and not measured. . . . [A]s is shown in FIG. 1C, ambient air containing VOCs [volatile organic compounds] and NO [nitric oxide] 189 is filtered to remove all ambient VOCs and NO 190. In this manner, clean air is passed to the human lung 198 devoid of VOCs and NO. The breath is exhaled 199 and the lung is washed. Wang 148; see also id. 146 & Fig. 1A (substantially similar disclosure). The Examiner reasons “filtered ambient air is no longer ambient air as it has been put through a filtering process which no longer makes it ambient air but instead filtered ambient air.” Final Act. 2; see also Ans. 3 (Wang’s “filter is designed prior to use to remove VOCs and NO from an air sample in a predetermined and standardized manner” and “produces] a purified clean air sample with a predetermined and standardized composition of VOCs and NO”). The Examiner relies on page 10 of Appellants’ Specification, which states: “In one preferred aspect of the invention, the predetermined gas composition is purified or filtered air" Spec. 10:3—4 (emphasis added); Final Act. 2; Adv. Act. 2 (further citing Spec. 18:4—6, describing “[t]he breathe in was filtered room air”). According to the Examiner, the Specification thereby supports the determination that Wang’s supply of filtered ambient air meets the limitation of claim 1. Final Act. 2. 3 Appeal 2017-000581 Application 13/423,527 Appellants assert Wang’s supply of ambient air having been filtered to be free of VOCs and NO is not the administration of a predetermined purified and standardized gas composition not comprising ambient air, as claimed. Appeal Br. 7—8. Appellants assert Wang’s air supply, instead, “is filtered ambient air” and “therefore is not predetermined since it includes ambient conditions that are not predetermined and since it does include filtered ambient air.” Id. at 7; Reply Br. 2—3. Appellants admit “purified or filtered air is . . . one example of the predetermined purified and standardized gas composition,” but contend the Examiner’s reading of Appellants’ Specification takes the phrase “purified or filtered air” out of context within the following passage: In one preferred aspect of the invention, the predetermined gas composition is purified or filtered air. What is important here is the universality of the gas composition used so that the tests do not include contaminants and have universality of location relevancy. While purity is important, the universality of the gas administered is also of importance. If one does not use “bone dry calibration gas” then it is preferable to use some other composition that has been determined and purified so that the test results are comparatively relevant. Spec. 10:3—18; Appeal Br. 7—8. We agree with Appellants that the Examiner has applied an overly broad construction of claim 1 in finding Wang discloses administration of a predetermined gas composition. A person of ordinary skill in the art, upon reading Appellants’ Specification at page 10, lines 3—18 (as set forth above), would understand the predetermined gas composition limitation of claim 1 4 Appeal 2017-000581 Application 13/423,527 requires administration of the same gas composition to the subject, regardless of location. See also Spec. 9:10-21 (“[ijnthe ‘wash-out,’ the lungs are cleansed using a predetermined gas composition, e.g., a prepared gas composition''’ to provide “a pre-defmed blank slate against which to measure analytes regardless of the ambient air to which the patient has been subjected” by creating “a baseline . . . wherein local contaminants are minimized and all patients start the testing at the same baseline regardless of where they live or where they are tested’'’) (emphases added). Wang’s removal of VOCs and NO from ambient air does not result in the claimed predetermined gas composition, because Wang does not thereby disclose administering the same gas composition to the subject, regardless of location. Instead, Wang predetermines only that the gas composition given to the subject air will not contain VOCs and NO. The ambient air at a first location will differ from the ambient air at a second location in many ways—including but not limited to VOC and NO composition—but Wang does not disclose controlling for all such factors to administer the same gas composition regardless of location. Thus, Wang’s administered gas composition is not predetermined. For the foregoing reasons, we do not sustain the rejection of claim 1 as anticipated by Wang. We likewise do not sustain the rejection of claims 3,12, and 13, each of which depend from claim 1 (Appeal Br. (Claim App.)), as anticipated by Wang. Independent claim 15, like claim 1, recites administration of a predetermined gas composition not comprising ambient air. Appeal Br. (Claims App.). We, therefore, likewise do not sustain the rejection of claim 15 as anticipated by Wang. 5 Appeal 2017-000581 Application 13/423,527 B. Obviousness based on Wang Claims 4—6, 9, and 11 each depend directly or indirectly from claim 1. Appeal Br. (Claim App.). The Examiner’s obviousness analysis concerning the subject matter added by these dependent claims does not cure the deficiency of Wang as to claim 1, noted above. See Final Act. 6—9; Ans. 5. For the reasons provided above in connection with claim 1, we do not sustain the rejection of claims 4—6, 9, and 11 as unpatentable over Wang. Independent claim 16, like claim 1, recites administration of a predetermined gas composition not comprising ambient air. Appeal Br. (Claims App.) The Examiner relies on Wang as disclosing that limitation in claim 16. Final Act. 10. For the reasons provided above in connection with claim 1, we do not sustain the rejection of claim 16 as unpatentable over Wang. C. Obviousness based on Wang and Restrepo Claims 7, 8, and 10 each depend directly or indirectly from claim 1. Appeal Br. (Claim App.). The Examiner’s obviousness analysis concerning the subject matter added by these dependent claims does not cure the deficiency of Wang as to claim 1, noted above. See Final Act. 10-13; Ans. 4—5. For the reasons provided above in connection with claim 1, we do not sustain the rejection of claims 7, 8, and 10 as unpatentable over Wang and Restrepo. D. Obviousness based on Wang and Clemensen Claim 14 depends indirectly from claim 1. Appeal Br. (Claim App.). The Examiner’s obviousness analysis concerning the subject matter added by claim 14 does not cure the deficiency of Wang as to claim 1, noted above. 6 Appeal 2017-000581 Application 13/423,527 See Final Act. 14; Ans. 5. For the reasons provided above in connection with claim 1, we do not sustain the rejection of claim 14 as unpatentable over Wang and Clemensen. DECISION The Examiner’s rejections of claims 1 and 3—16 are each reversed. REVERSED 7 Copy with citationCopy as parenthetical citation